MD2324F1 - Metabolism regulating medicament - Google Patents
Metabolism regulating medicament Download PDFInfo
- Publication number
- MD2324F1 MD2324F1 MD20030188A MD20030188A MD2324F1 MD 2324 F1 MD2324 F1 MD 2324F1 MD 20030188 A MD20030188 A MD 20030188A MD 20030188 A MD20030188 A MD 20030188A MD 2324 F1 MD2324 F1 MD 2324F1
- Authority
- MD
- Moldova
- Prior art keywords
- metabolism regulating
- regulating medicament
- medicament
- encephalon
- ergocalciferol
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 230000004060 metabolic process Effects 0.000 title abstract 2
- 230000001105 regulatory effect Effects 0.000 title 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 abstract 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 abstract 1
- 229940095618 calcium glycerophosphate Drugs 0.000 abstract 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 229960002061 ergocalciferol Drugs 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 abstract 1
- 235000019136 lipoic acid Nutrition 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 abstract 1
- 238000010606 normalization Methods 0.000 abstract 1
- 235000019488 nut oil Nutrition 0.000 abstract 1
- 239000010466 nut oil Substances 0.000 abstract 1
- 229940069337 potassium orotate Drugs 0.000 abstract 1
- DHBUISJCVRMTAZ-UHFFFAOYSA-M potassium;2,4-dioxo-1h-pyrimidine-6-carboxylate Chemical compound [K+].[O-]C(=O)C1=CC(=O)NC(=O)N1 DHBUISJCVRMTAZ-UHFFFAOYSA-M 0.000 abstract 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 abstract 1
- 229960005205 prednisolone Drugs 0.000 abstract 1
- 229960003471 retinol Drugs 0.000 abstract 1
- 235000020944 retinol Nutrition 0.000 abstract 1
- 239000011607 retinol Substances 0.000 abstract 1
- 208000007442 rickets Diseases 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229960002663 thioctic acid Drugs 0.000 abstract 1
- 229940042585 tocopherol acetate Drugs 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 abstract 1
- 235000001892 vitamin D2 Nutrition 0.000 abstract 1
- 239000011653 vitamin D2 Substances 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
The invention refers to medicine, namely to pharmacology and may be used for normalization of metabolic processes, compensation of the absolute or relative deficit of vitamins and mineral substances, in case of encephalon trauma, as well as for treatment of children up to 3 years, suffering from neurologic diseases and rickets. The medicament contains the following ingredients, in the ratio: calcium glycerophosphate 1,5...2,0 g; potassium orotate 1,0...2,0 g; lipoic acid 1,0...2,0 g; prednisolone 0,01...0,02 g; retinol 10000...20000 IU; ergocalciferol 5000...10000 IU; tocopherol acetate 300...6000 IU; folic acid 0,01...0,02 g and pasteurized nut oil 90...100 ml.Claims: 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20030188A MD2324G2 (en) | 2003-07-25 | 2003-07-25 | Metabolism regulating medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20030188A MD2324G2 (en) | 2003-07-25 | 2003-07-25 | Metabolism regulating medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD2324F1 true MD2324F1 (en) | 2003-12-31 |
| MD2324G2 MD2324G2 (en) | 2004-07-31 |
Family
ID=32026194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20030188A MD2324G2 (en) | 2003-07-25 | 2003-07-25 | Metabolism regulating medicament |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD2324G2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2591811C1 (en) * | 2015-06-25 | 2016-07-20 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей" Министерства здравоохранения Российской Федерации | Method of treating metabolic syndrome in emotiogenic type of eating behaviour |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD2904G2 (en) * | 2005-04-12 | 2006-06-30 | Каролина ВАРВАРЮК | Use of Gerovital H3 preparation for treatment of central nervous system affections to children |
| MD2903G2 (en) * | 2005-04-12 | 2006-06-30 | Ион ИЛИЧУК | Medicinal remedy for treatment of central and peripheral nervous system to children |
| MD3425G2 (en) * | 2007-05-17 | 2008-06-30 | ИЛИЧУК Ион | Method of prophylaxis and treatment of nervous system pathologies to children |
| MD501Z (en) * | 2011-06-30 | 2012-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for prophylaxis of postradiation complications in oncologic diseases |
-
2003
- 2003-07-25 MD MDA20030188A patent/MD2324G2/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2591811C1 (en) * | 2015-06-25 | 2016-07-20 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей" Министерства здравоохранения Российской Федерации | Method of treating metabolic syndrome in emotiogenic type of eating behaviour |
Also Published As
| Publication number | Publication date |
|---|---|
| MD2324G2 (en) | 2004-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5597585A (en) | Vitamin/mineral composition | |
| US6582723B2 (en) | Cancer immune composition for prevention and treatment of individuals | |
| Yun et al. | Protective effect of Chlorella vulgaris against lead-induced oxidative stress in rat brains | |
| AU2008313418A8 (en) | Composition for regulating lipid metabolism | |
| US20240350569A1 (en) | Nutritional Composition | |
| AU2466500A (en) | Pharmaceutical compositions for alleviating discomfort | |
| CY1112547T1 (en) | Means Containing Folic Acid, Vitamin B6 And Vitamin B12, And Their Use | |
| BR0214838A (en) | Composition for promoting bone growth and maintaining bone health | |
| WO2005051323A3 (en) | Vitamin d analogs for obesity prevention and treatment | |
| WO2006099233B1 (en) | Compositions and methods for the treatment of osteoporosis and inflammatory joint disease | |
| WO2004014953A3 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
| Afifi | Effect of camel’s milk on cisplatin-induced nephrotoxicity in Swiss albino mice | |
| WO2006044101A3 (en) | Method and composition for supplementation of nutritional deficiencies in renal patients | |
| MD2324G2 (en) | Metabolism regulating medicament | |
| CN107257676A (en) | Hair Tonic or Dietary Supplement | |
| WO2004058268A3 (en) | Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders | |
| US20180289740A1 (en) | Nutritional composition for providing relief from wine induced headaches | |
| UA86399C2 (en) | Normal;heading 1;heading 2;USE OF 2,5-DIHYDROXYBENZENESULPHONIC ACID IN THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF ANGIODEPENDENT DISEASES | |
| AU2003224107A1 (en) | Soluble composition containing sporopollenin and the use thereof | |
| WO2011041920A8 (en) | Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing | |
| UA91028C2 (en) | Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress | |
| MD2903G2 (en) | Medicinal remedy for treatment of central and peripheral nervous system to children | |
| Mehrjardi et al. | Determination of phytic acid content in different types of bread and dough consumed in Yazd, Iran | |
| Al-Basrawi et al. | Antioxidant Effect of Folic Acid and its Relation to Salivary Proteins and Oral Health | |
| US12440504B1 (en) | Energy drink composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |